We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer.
- Authors
AGIANNITOPOULOS, KONSTANTINOS; PEPE, GEORGIA; PAPADOPOULOU, EIRINI; TSAOUSIS, GEORGIOS N.; KAMPOURI, STAVROULA; MARAVELAKI, SONIA; FASSAS, ATHANASSIOS; CHRISTODOULOU, CHRISTOS; IOSIFIDOU, RODONIKI; KARAGEORGOPOULOU, SOFIA; MARKOPOULOS, CHRISTOS; NATSIOPOULOS, IOANNIS; PAPAZISIS, KONSTANTINOS; VASILAKI-ANTONATOU, MARIA; VENIZELOS, VASSILEIOS; OZMEN, VAHIT; TANSAN, SUALP; KABAN, KERIM; ENIU, DAN TUDOR; CHIOREAN, ANGELICA
- Abstract
Background: Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate the occurrence of SVs in hereditary cancer genes and the clinical utility of RNA analysis. Material and Methods: 1518 individuals were tested for cancer predisposition, using a Next Generation Sequencing (NGS) panel of 36 genes. Splicing variant analysis was performed using RT-PCR and Sanger Sequencing. Results: In total, 34 different SVs were identified, 53% of which were classified as pathogenic or likely pathogenic. The remaining 16 variants were initially classified as Variant of Uncertain Significance (VUS). RNA analysis was performed for 3 novel variants. Conclusion: The RNA analysis assisted in the reclassification of 20% of splicing variants from VUS to pathogenic. RNA analysis is essential in the case of uncharacterized splicing variants, for proper classification and personalized management of these patients.
- Subjects
RNA analysis; NON-coding RNA; GENETIC engineering; FUNCTIONAL analysis; CANCER genes
- Publication
Cancer Genomics & Proteomics (1109-6535), 2021, Vol 18, Issue 3, p285
- ISSN
1109-6535
- Publication type
Article
- DOI
10.21873/cgp.20259